Investing.com - AbbVie (NYSE:ABBV) reported on Wednesday fourth quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
AbbVie announced earnings per share of $3.31 on revenue of $14.89B. Analysts polled by Investing.com anticipated EPS of $3.29 on revenue of $14.96B.
AbbVie shares are up 1% from the beginning of the year, still down 0.95% from its 52 week high of $138.30 set on January 27. They are outperforming the S&P 500 which is down 4.61% from the start of the year.
AbbVie shares gained 0.72% in pre-market trade following the report.
AbbVie follows other major Healthcare sector earnings this month
AbbVie's report follows an earnings beat by J&J on January 25, who reported EPS of $2.13 on revenue of $24.8B, compared to forecasts EPS of $2.12 on revenue of $25.28B.
UnitedHealth had beat expectations on January 19 with fourth quarter EPS of $4.48 on revenue of $73.74B, compared to forecast for EPS of $4.3 on revenue of $72.98B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar